Merel C. van Maarle

2.2k total citations
29 papers, 788 citations indexed

About

Merel C. van Maarle is a scholar working on Surgery, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Merel C. van Maarle has authored 29 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 9 papers in Pediatrics, Perinatology and Child Health and 5 papers in Molecular Biology. Recurrent topics in Merel C. van Maarle's work include Prenatal Screening and Diagnostics (9 papers), Lipoproteins and Cardiovascular Health (5 papers) and Congenital Anomalies and Fetal Surgery (4 papers). Merel C. van Maarle is often cited by papers focused on Prenatal Screening and Diagnostics (9 papers), Lipoproteins and Cardiovascular Health (5 papers) and Congenital Anomalies and Fetal Surgery (4 papers). Merel C. van Maarle collaborates with scholars based in Netherlands, United States and Sweden. Merel C. van Maarle's co-authors include Mariëtte Goddijn, Madelon van Wely, Merel M. J. van den Berg, Lidewij Henneman, Gouke J. Bonsel, E. Redeker, Marlies E. A. Stouthard, Eva Pajkrt, Phillis Lakeman and Ulf dé Fairé and has published in prestigious journals such as Genes & Development, Journal of Bone and Mineral Research and Atherosclerosis.

In The Last Decade

Merel C. van Maarle

29 papers receiving 771 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Merel C. van Maarle Netherlands	16	309	199	140	135	107	29	788
Tahsin Yakut Türkiye	15	174 0.6×	191 1.0×	117 0.8×	315 2.3×	61 0.6×	78	762
Claudette Hajaj Gonzalez Brazil	15	207 0.7×	196 1.0×	148 1.1×	193 1.4×	68 0.6×	33	712
Marie‐Claude Addor United Kingdom	16	316 1.0×	210 1.1×	139 1.0×	148 1.1×	26 0.2×	29	736
Melissa Maisenbacher United States	17	331 1.1×	401 2.0×	170 1.2×	511 3.8×	68 0.6×	33	1.0k
Christine M. Armour Canada	20	358 1.2×	435 2.2×	86 0.6×	340 2.5×	51 0.5×	52	923
Seyed Alireza Dastgheib Iran	13	189 0.6×	121 0.6×	200 1.4×	166 1.2×	105 1.0×	117	992
M L Martínez-Frías Spain	10	103 0.3×	152 0.8×	125 0.9×	113 0.8×	44 0.4×	20	459
Wiltrud Coerdt Germany	17	345 1.1×	346 1.7×	150 1.1×	372 2.8×	51 0.5×	42	998
Myra Wick United States	16	170 0.6×	299 1.5×	139 1.0×	397 2.9×	101 0.9×	55	1.1k
Inusha Panigrahi India	17	153 0.5×	254 1.3×	50 0.4×	267 2.0×	38 0.4×	145	1.0k

Countries citing papers authored by Merel C. van Maarle

Since Specialization

Citations

This map shows the geographic impact of Merel C. van Maarle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Merel C. van Maarle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merel C. van Maarle more than expected).

Fields of papers citing papers by Merel C. van Maarle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Merel C. van Maarle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Merel C. van Maarle. The network helps show where Merel C. van Maarle may publish in the future.

Co-authorship network of co-authors of Merel C. van Maarle

This figure shows the co-authorship network connecting the top 25 collaborators of Merel C. van Maarle. A scholar is included among the top collaborators of Merel C. van Maarle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Merel C. van Maarle. Merel C. van Maarle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dijk, Sandra van, et al.. (2024). Phenotype‐to‐Genotype Description of Prenatal Suspected and Postnatal Discovered Upper Limb Anomalies: A Retrospective Cohort Study. Prenatal Diagnosis. 45(1). 3–14. 2 indexed citations

Schreuder, Willem H., Arjen H.G. Cleven, Ruud Schreurs, et al.. (2023). Efficacy and Toxicity of Calcitonin Treatment in Children with Cherubism: A Single-Center Cohort Study. Journal of Bone and Mineral Research. 38(12). 1822–1833. 1 indexed citations

Tromp, Tycho R., M. Doortje Reijman, Albert Wiegman, et al.. (2022). Counseling couples at risk of having a child with homozygous familial hypercholesterolemia – Clinical experience and recommendations. Journal of clinical lipidology. 17(2). 291–296. 2 indexed citations

Vries, Reinier J. de, Bregje Jaeger, Debby M.E.I. Hellebrekers, et al.. (2021). Distal muscle weakness and optic atrophy without central nervous system involvement in a patient with a homozygous missense mutation in the C19ORF12-gene. Clinical Neurology and Neurosurgery. 206. 106637–106637. 1 indexed citations

Mathijssen, Inge B., et al.. (2018). Preconception carrier screening for multiple disorders: evaluation of a screening offer in a Dutch founder population. European Journal of Human Genetics. 26(2). 166–175. 22 indexed citations

Amsterdam, Karin Huijsdens–van, Roy Straver, Merel C. van Maarle, et al.. (2018). Mosaic maternal 10qter deletions are associated with FRA10B expansions and may cause false-positive noninvasive prenatal screening results. Genetics in Medicine. 20(11). 1472–1476. 13 indexed citations

Ferrer, Christina M., Mariëlle Alders, Alex V. Postma, et al.. (2018). An inactivating mutation in the histone deacetylase SIRT6 causes human perinatal lethality. Genes & Development. 32(5-6). 373–388. 34 indexed citations

Schendel, Rachèl V. van, Godelieve C.M.L. Page‐Christiaens, Lean Beulen, et al.. (2017). Women's Experience with Non‐Invasive Prenatal Testing and Emotional Well‐being and Satisfaction after Test‐Results. Journal of Genetic Counseling. 26(6). 1348–1356. 37 indexed citations

Mathijssen, Inge B., Merel C. van Maarle, E. Redeker, et al.. (2017). With expanded carrier screening, founder populations run the risk of being overlooked. Journal of Community Genetics. 8(4). 327–333. 9 indexed citations

10.

Schendel, Rachèl V. van, Godelieve C.M.L. Page‐Christiaens, Lean Beulen, et al.. (2016). Trial by Dutch laboratories for evaluation of non‐invasive prenatal testing. Part II—women's perspectives. Prenatal Diagnosis. 36(12). 1091–1098. 55 indexed citations

11.

Mathijssen, Inge B., Phillis Lakeman, Merel C. van Maarle, et al.. (2016). Factors for successful implementation of population-based expanded carrier screening: learning from existing initiatives: Table 1. European Journal of Public Health. 27(2). ckw110–ckw110. 25 indexed citations

12.

Beeldman, Emma, Anneke J. van der Kooi, Marianne de Visser, et al.. (2015). A Dutch family with autosomal recessively inherited lower motor neuron predominant motor neuron disease due to optineurin mutations. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 16(5-6). 410–411. 15 indexed citations

13.

Mathijssen, Inge B., Lidewij Henneman, Phillis Lakeman, et al.. (2015). Targeted carrier screening for four recessive disorders: High detection rate within a founder population. European Journal of Medical Genetics. 58(3). 123–128. 23 indexed citations

14.

Semaka, Alicia, Chris Kay, Emilia K. Bijlsma, et al.. (2014). A new mutation for Huntington disease following maternal transmission of an intermediate allele. European Journal of Medical Genetics. 58(1). 28–30. 10 indexed citations

15.

Berg, Merel M. J. van den, Merel C. van Maarle, Madelon van Wely, & Mariëtte Goddijn. (2012). Genetics of early miscarriage. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1822(12). 1951–1959. 192 indexed citations

16.

Vos, Yvonne J., Hermien E. K. de Walle, Arjan Stegeman, et al.. (2009). Genotype–phenotype correlations in L1 syndrome: a guide for genetic counselling and mutation analysis. Journal of Medical Genetics. 47(3). 169–175. 61 indexed citations

17.

Lange, Jan de, Merel C. van Maarle, Hans P. van den Akker, & E. Redeker. (2006). DNA analysis of the SH3BP2 gene in patients with aggressive central giant cell granuloma. British Journal of Oral and Maxillofacial Surgery. 45(6). 499–500. 23 indexed citations

18.

Maarle, Merel C. van, Marlies E. A. Stouthard, & Gouke J. Bonsel. (2002). Risk perception of participants in a family‐based genetic screening program on familial hypercholesterolemia. American Journal of Medical Genetics Part A. 116A(2). 136–143. 17 indexed citations

19.

Maarle, Merel C. van, et al.. (2002). Follow up after a family based genetic screening programme for familial hypercholesterolaemia: is screening alone enough?. BMJ. 324(7350). 1367.1–1368. 10 indexed citations

20.

Maarle, Merel C. van, et al.. (2001). How Disturbing Is It to Be Approached for a Genetic Cascade Screening Programme for Familial Hypercholesterolaemia?. Public Health Genomics. 4(4). 244–252. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact